Skip to main content
Premium Trial:

Request an Annual Quote

MAG's GeneMine 3.5 To Speed Gene Discovery

Premium

PALO ALTO, Calif.--Molecular Applications Group announced the introduction of GeneMine 3.5, an upgrade of its software tool used to predict gene function.

"By reducing the time necessary to analyze gene function from weeks to hours, it relieves a major bottleneck in pharmaceutical research," said Thomas Hatton, director of product planning. "This latest version adds broader platform support and a number of features that will make analysis still faster and more convenient."

The company said the added features include: compatibility with Sun/Solaris 2.5.1 and Intel/Red Hat Linux 5.1+ platforms; automatic retrieval of top sequence homologs after a comprehensive sequence analysis run; comprehensive sequence analysis from the command line; the ability to bypass the program data cache when performing analyses, to ensure that time-sensitive annotation information is as current as possible; a tool for viewing the original, unprocessed output from servers, including raw data and informational messages in the program's information window; the ability to generate reverse complements of nucleotide sequences to allow loading and aligning of related nucleotide and protein sequences; and flexible license check-out procedures that allow users of Look and GeneMine on the same site to sign out licenses on an as-needed basis.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.